US2006223990A1PendingUtilityA1

Synthesis, deprotection, analysis & purification of RNA & ribozymes

Assignee: SIRNA THERAPEUTICS INCPriority: May 11, 1992Filed: Sep 9, 2005Published: Oct 5, 2006
Est. expiryMay 11, 2012(expired)· nominal 20-yr term from priority
A61P 31/22A61P 35/02A61P 31/18A61P 31/12A61P 31/14A61P 31/16C12N 15/86A61P 1/16C12N 2310/3521C12Q 1/706A61K 38/00C12N 2310/123C12N 2310/321C07H 19/06C12N 15/113C12N 15/1003C12N 2710/16622C12N 2740/14043C12N 2730/10122C12N 15/85C12N 2310/121C12N 2310/3535C12N 2310/53C12N 2310/12C12N 2770/24222C12N 2310/122C12N 2310/111C12N 2310/3533C12N 2310/315C12N 2310/322C12Q 1/701C12N 2310/3531C12N 15/1131C07K 14/005
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.

Claims

exact text as granted — not AI-modified
1 . A process for chemically synthesizing, deprotecting, and purifying RNA having one or more chemical modifications, comprising: 
 a. contacting a phosphoramidite with S-alkyltetrazole under conditions for synthesizing said RNA;    b. contacting said RNA with an alkylamine under conditions for removing any exocyclic amine protecting groups or phosphate ester protecting groups;    c. contacting said RNA with triethylamine-hydrogen fluoride under conditions to remove any alkylsilyl protecting groups from said RNA;    d. loading said RNA onto an anion exchange high-performance liquid chromatography (HPLC) column;    e. eluting said RNA by passing a buffer through said column; and    f. collecting the eluate from said column and recovering said RNA from said eluate, under conditions which allow for the purification of said RNA.    
     
     
         2 . The process of  claim 1 , wherein said RNA is provided as a sodium, potassium, or magnesium salt.  
     
     
         3 . The process of  claim 1 , wherein said RNA is provided in desalted form.  
     
     
         4 . The process of  claim 1 , wherein said anion exchange column comprises resins that are either quaternary or tertiary amino derivatized stationary phases.  
     
     
         5 . The process of  claim 4 , wherein said resin is either silica-based or polystyrene based.  
     
     
         6 . The process of  claim 1 , wherein said RNA comprises a plurality of chemical modifications.  
     
     
         7 . The process of  claim 1 , wherein said chemical modification is a sugar modification.  
     
     
         8 . The process of  claim 1 , wherein said chemical modification is a base modification.  
     
     
         9 . The process of  claim 1 , wherein said chemical modification is a phosphate backbone modification.  
     
     
         10 . The process of  claim 7 , wherein said sugar modification is a 2′-O-methyl modification.  
     
     
         11 . The process of  claim 7 , wherein said sugar modification is a 2′-deoxy-2′-amino modification.  
     
     
         12 . The process of  claim 7 , wherein said sugar modification is a 2′-deoxy-2′-fluoro modification.  
     
     
         13 . The process of  claim 9 , wherein said phosphate backbone modification is a phosphorothioate modification.  
     
     
         14 . The process of  claim 1 , wherein said RNA is chemically synthesized using solid phase synthesis.  
     
     
         15 . The process of  claim 1 , wherein said S-alkyltetrazole is S-ethyltetrazole.  
     
     
         16 . The process of  claim 1 , wherein said alkylamine is methylamine.  
     
     
         17 . The process of  claim 1 , wherein said alkylamine is ethylamine.  
     
     
         18 . The process of  claim 1 , wherein said alkylamine is triethylamine.

Join the waitlist — get patent alerts

Track US2006223990A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.